ERJ staff report (DS)
Atlanta, Georgia -- Vystar Corp. has
appointed Jack Callicutt as chief financial officer. He replaces
Mrs. Linda Hammock, who was Vystar's acting CFO through its development stage and
has now focused her attention on other development stage companies.
Previously, Callicutt was chief financial officer at Tikvah Therapeutics, a clinical-stage
biopharmaceutical company. His accomplishments in previous roles include private
placements of common stock and negotiating a corporate merger,.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Vystar